Korea’s Celltrion Initiates Clinical Trials Of Roche’s Rituxan Biosimilar
This article was originally published in PharmAsia News
Executive Summary
Celltrion takes a step forward in its biosimilar ambitions by commencing clinical trials of a key pipeline product.